Collins J C, Sarfeh I J
Surgical Service, Long Beach Veterans Affairs Medical Center, CA 90822, USA.
West J Med. 1995 Jun;162(6):527-35.
Portal hypertension is frequently complicated by upper gastrointestinal tract bleeding and ascites. Hemorrhage from esophageal varices is the most common cause of death from portal hypertension. Medical treatment, including resuscitation, vasoactive drugs, and endoscopic sclerosis, is the preferred initial therapy. Patients with refractory hemorrhage frequently are referred for immediate surgical intervention (usually emergency portacaval shunt). An additional cohort of patients with a history of at least 1 episode of variceal hemorrhage is likely to benefit from elective shunt operations. Shunt operations are classified as total, partial, or selective shunts based on their hemodynamic characteristics. Angiographically created shunts have been introduced recently as an alternative to operative shunts in certain circumstances. Devascularization of the esophagus or splenectomy is done for specific indications. Medically intractable ascites is a separate indication for surgical intervention. Liver transplantation has been advocated for patients whose portal hypertension is a consequence of end-stage liver disease. In the context of an increasingly complex set of treatment options, we present an overview of surgical therapy for complications of portal hypertension.
门静脉高压常并发上消化道出血和腹水。食管静脉曲张出血是门静脉高压最常见的死亡原因。包括复苏、血管活性药物和内镜硬化治疗在内的内科治疗是首选的初始治疗方法。难治性出血的患者常被转诊接受立即手术干预(通常是急诊门腔分流术)。另一组有至少1次静脉曲张出血病史的患者可能从择期分流手术中获益。分流手术根据其血流动力学特征分为完全分流、部分分流或选择性分流。血管造影创建的分流术最近已被引入,作为某些情况下手术分流的替代方法。食管去血管化或脾切除术用于特定指征。内科治疗难以控制的腹水是手术干预的另一个指征。对于门静脉高压是终末期肝病后果的患者,有人主张进行肝移植。在一系列日益复杂的治疗选择背景下,我们概述了门静脉高压并发症的外科治疗。